V. A. Kushnir, D. H. Barad, D. F. Albertini, S. K. Darmon, and N. Gleicher, Systematic review of worldwide trends in assisted reproductive technology, Reprod Biol Endocrinol, vol.15, 2004.

Y. Andersen, C. , V. Andersen, and K. , Improving the luteal phase after ovarian stimulation: reviewing new options, Reproductive BioMedicine Online, vol.28, p.24656557, 2014.

D. D. Carson, Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening, Molecular Human Reproduction, vol.8, p.12200466, 2002.

M. Wetendorf and F. J. Demayo, The progesterone receptor regulates implantation, decidualization, and glandular development via a complex paracrine signaling network, Mol Cell Endocrinol, vol.357, p.22115959, 2012.

B. C. Fauser, D. De-jong, F. Olivennes, H. Wramsby, C. Tay et al., Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization, J Clin Endocrinol Metab, vol.87, p.11836309, 2002.

T. Child, S. A. Leonard, J. S. Evans, and A. Lass, Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles, Reprod Biomed Online, vol.36, p.29550390, 2018.

M. Van-der-linden, K. Buckingham, C. Farquhar, J. Kremer, and M. Metwally, Luteal phase support for assisted reproduction cycles, Cochrane Database Syst Rev, vol.009154, p.26148507, 2015.

E. Labarta, G. Mariani, N. Holtmann, P. Celada, J. Remohí et al., Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study, Hum Reprod, vol.32, p.29040638, 2017.

J. L. Yovich, J. L. Conceicao, J. D. Stanger, P. M. Hinchliffe, and K. N. Keane, Mid-luteal serum progesterone concentrations govern implantation rates for cryopreserved embryo transfers conducted under hormone replacement, Reprod Biomed Online, vol.31, p.26099447, 2015.

B. Alsbjerg, L. Thomsen, H. O. Elbaek, R. Laursen, B. B. Povlsen et al., Progesterone levels on pregnancy test day after hormone replacement therapy-cryopreserved embryo transfer cycles and related reproductive outcomes, Reprod Biomed Online, vol.37, p.30385142, 2018.

L. H. Thomsen, U. S. Kesmodel, K. Erb, L. Bungum, D. Pedersen et al., The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF/ICSI cycles, Hum Reprod, 2018.

, , p.29955789

C. A. Venetis, B. W. Mol, and E. M. Kolibianakis, Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence?, Hum Reprod, vol.33, p.30325399, 2018.

H. Tournaye, G. T. Sukhikh, E. Kahler, and G. Griesinger, A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization, Hum Reprod, vol.32, pp.1019-1027, 2017.

B. Abbott, V. film-coated tablets 10 mg Summary of Product Characteristics, 2017.
URL : https://hal.archives-ouvertes.fr/in2p3-00123118

G. Griesinger, C. Blockeel, and H. Tournaye, Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard?, Fertil Steril, vol.109, p.29778368, 2018.

G. Griesinger, H. Tournaye, N. Macklon, F. Petraglia, P. Arck et al., Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction, Reprod Biomed Online, vol.38, p.30595525, 2019.

B. N. Chakravarty, H. H. Shirazee, P. Dam, S. K. Goswami, R. Chatterjee et al., Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study, J Steroid Biochem Mol Biol, vol.97, p.16213136, 2005.

A. Patki and V. C. Pawar, Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone, Gynecol Endocrinol, vol.23, issue.1, p.17943542, 2007.

A. Ganesh, N. Chakravorty, R. Mukherjee, S. Goswami, K. Chaudhury et al., Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study, Fertil Steril, vol.95, p.21333984, 2011.

V. Tomic, J. Tomic, D. Z. Klaic, M. Kasum, and K. Kuna, Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial, Eur J Obstet Gynecol Reprod Biol, vol.186, p.25622239, 2015.

N. Saharkhiz, M. Zamaniyan, S. Salehpour, S. Zadehmodarres, S. Hoseini et al., A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles, Gynecol Endocrinol, vol.32, p.26486011, 2016.

A. Sharaf, L. H. Kombian, S. B. Diejomaoh, and F. , Determination of Dydrogesterone in Human Plasma by Tandem Mass Spectrometry: Application to Therapeutic Drug Monitoring of Dydrogesterone in Gynecological Disorders, Chroma, vol.64, pp.287-292, 2006.

X. Zhu, H. Ye, and Y. Fu, Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation, Fertil Steril, vol.108, p.28697910, 2017.

S. Yu, H. Long, H. Chang, Y. Liu, H. Gao et al., New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles, Hum Reprod, vol.33, p.29300975, 2018.

D. G. Altman, B. Lausen, W. Sauerbrei, and M. Schumacher, Dangers of using "optimal" cutpoints in the evaluation of prognostic factors, J Natl Cancer Inst, vol.86, p.8182763, 1994.

B. W. Mol, P. M. Bossuyt, S. K. Sunkara, G. Velasco, J. A. Venetis et al., Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients, Fertil Steril, vol.109, p.29935655, 2018.

R. J. Paulson, M. G. Collins, and V. I. Yankov, Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert, J Clin Endocrinol Metab, vol.99, p.24606090, 2014.

E. Cicinelli, D. De-ziegler, C. Bulletti, M. G. Matteo, L. M. Schonauer et al., Direct transport of progesterone from vagina to uterus, Obstet Gynecol, vol.95, p.10711552, 2000.

W. E. Gibbons, J. P. Toner, P. Hamacher, and P. Kolm, Experience with a novel vaginal progesterone preparation in a donor oocyte program, Fertil Steril, vol.69, p.9457941, 1998.